INSMED INC (INSM)
NASDAQ • Healthcare
Last close at August 6, 2026 at 20:00 UTC
Fundamentals Charts
About INSMED INC
Insmed Incorporated is a biotechnology company listed on the NASDAQ under INSM that develops and commercializes therapies for serious diseases, with $606.4 million in revenue in FY2025. Its business today centers on ARIKAYCE, while its research pipeline extends into rare lung disease and other neutrophil-driven disorders.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
INSMED INC's Technical Indicators Summary
INSM trades around 132.55 and presents a predominantly bullish short-to-intermediate picture driven by strong momentum and moving-average alignment. ADX near 25 indicates a firm trend, while very high CCI and a positive MACD support upward momentum even as RSI reads overbought. The stock is well above its short and medium moving averages and the classic pivot sits far below current levels, though it remains below the 200-day averages, which tempers the long-term view. ATR is moderate and OBV is strongly positive, suggesting volume supports the advance. Technical takeaway: Buy — momentum-led strength with some longer-term resistance.
| Indicator | Value |
|---|---|
RSI (14) | 75.89 |
Stochastic %K (14, 3, 3) | 40.78 |
CCI (20) | 359.24 |
WPR (14) | -12.48 |
Momentum (10) | 25.14 |
MFI | 57.30 |
MACD Level (12, 26) | 0.25 |
Bollinger Bands | $91.76 - $122.03 |
ATR (14) | $6.31 (4.76%) |
ADX (14) | 24.65 |
OBV | 21,897,084 |
Classic Pivot Point | $99.54 |
Fibonacci Pivot Point | $99.54 |
Simple Moving Averages | $104.78 - $146.48(5 indicators) |
Exponential Moving Averages | $106.65 - $135.14(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Despite intraday swings, INSM preserved the bulk of its 33.86% gap versus yesterday. The session finished with INSM recording off-the-charts activity at 3.06× its average volume. INSM's BRINSUPRI Q2 results lift full-year revenue guidance to $1.25-$1.4B and lift peak sales above $7B.
Trading Volume
Above 10d avg 3.9M
11.9M
vs S&P 500 Today
Strong Outperformance
+34.11%
52-Week Position
Lower range
34.5%
Updated: August 6, 2026 at 20:57 UTC